Lessons from UCB's Journey: Innovation, Patient-Centricity, and Digital Transformation

The pharmaceutical industry faces complex challenges—ranging from rapidly changing technologies to balancing patient needs with commercial interests. Recent reports show that while pharma companies are heavily investing in R&D, with expenditure ranging from around 14% to 50% of their revenues, only a small fraction of these efforts translates into groundbreaking therapies that reach patients. Additionally, as healthcare systems become more complex, there is a growing need for a patient-centric approach that balances innovation with operational efficiency, always keeping the patient at the center of these efforts.